glac Biotech Co., Ltd. Share Price

Equities

6553

TW0006553001

End-of-day quote Taipei Exchange 04:30:00 09/12/2019 am IST 5-day change 1st Jan Change
43.12 TWD +0.05% Intraday chart for glac Biotech Co., Ltd. +0.14% -.--%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2017 80Cr 2.48Cr 206.34Cr Sales 2018 99Cr 3.08Cr 256Cr Capitalization 238.09Cr 7.4Cr 616.35Cr
Net income 2017 5.1Cr 15.86L 13Cr Net income 2018 9.5Cr 29.54L 25Cr EV / Sales 2017 1.37 x
Net cash position 2017 78Cr 2.44Cr 203.03Cr Net cash position 2018 52Cr 1.61Cr 134.04Cr EV / Sales 2018 1.88 x
P/E ratio 2017
42.3 x
P/E ratio 2018
25 x
Employees -
Yield 2017
10%
Yield 2018
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 05/08/05
Director of Finance/CFO - 07/14/07
Chief Tech/Sci/R&D Officer - 05/08/05
Members of the board TitleAgeSince
Director/Board Member - 30/08/30
Director/Board Member 71 -
Chairman 70 21/08/21
More insiders
Glac Biotech Co Ltd is a Taiwan-based company principally engaged in research and development, manufacturing and sale of probiotics- and fermentation-related application products. The Company manufactures microencapsulated functional probiotic powder, leavening agents, as well as application products such as fermented concentrated solution and others. Its products are applied in medicine, health food, food, animal husbandry and other areas. The Company mainly distributes its products to Mainland China, Taiwan and other markets.
Sector
-
More about the company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW